CoChat

Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

Open access
Keyif, Betül, Yavuzcan, Ali · 2025 · Medicina

The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index; 17 of the 26 sources its claims cite were checked for support.

Abstract

Background and Objectives: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. Women with PCOS often have metabolic disorders such as insulin resistance (IR), type 2 diabetes (T2DM), obesity, and metabolic syndrome (MetS). The assessment of visceral adiposity and dysfunctional adipose tissue is crucial for understanding the metabolic risks associated with PCOS. The visceral adiposity index (VAI) and the dysfunctional adiposity index (DAI) are two novel metabolic indices that more specifically assess adipose tissue dysfunction and visceral fat accumulation. This study aimed to evaluate the clinical utility of VAI and DAI as predictive markers for metabolic complications such as insulin resistance (IR) and metabolic syndrome (MetS) in women with PCOS. Materials and Methods: This cross-sectional study included 92 women diagnosed with PCOS based on the 2023 revised Rotterdam criteria, as well as 68 healthy controls. Anthropometric and biochemical parameters, including fasting glucose, insulin, lipid profile, and hormonal markers, were recorded. VAI and DAI were calculated using established formulas derived from previous validated studies. Results: The mean VAI in PCOS patients was 4.26 ± 3.23, compared to 2.61 ± 1.92 in controls (p = 0.003). The mean DAI in PCOS patients was 3.00 ± 1.86, while in controls it was 1.86 ± 1.22 (p = 0.003). Both VAI (Area Under the Curve [AUC] = 0.639) and DAI (AUC = 0.635) did not demonstrate statistically significant diagnostic performance for PCOS itself, but they were strongly associated with metabolic disturbances within the PCOS group. VAI and DAI values were significantly elevated in PCOS patients with IR (p < 0.001) and MetS (p < 0.001). For MetS in PCOS patients, VAI demonstrated the highest predictive ability, with an AUC of 0.87 and a cutoff of 4.73 (sensitivity 62%, specificity 92%), while DAI had an AUC of 0.86 with a cutoff of 2.44 (sensitivity 74%, specificity 80%). Regarding IR in PCOS patients, VAI had an AUC of 0.75 with a cutoff of 2.56 (sensitivity 82%, specificity 56%), while DAI had an AUC of 0.74 with a cutoff of 1.59, showing a sensitivity of 82% and a specificity of 55%. Conclusions: Although VAI and DAI are not suitable for diagnosing PCOS, they provide valuable insights into the metabolic risks associated with the condition. VAI and DAI can serve as promising biomarkers for identifying IR and MetS risk in women with PCOS. Their integration into clinical practice may facilitate the early detection of cardiometabolic complications, offering a more specific metabolic risk assessment compared to traditional anthropometric measures.

Overview

CoChat Summary

## TL;DR

This retrospective cross-sectional study of 92 women with PCOS and 68 age-matched healthy controls found that visceral adiposity index (VAI) and dysfunctional adiposity index (DAI) were higher in PCOS and were associated with insulin resistance and metabolic syndrome, but they were not good diagnostic tools for PCOS itself. The authors conclude VAI and DAI may be useful screening markers for metabolic risk in PCOS, especially for MetS and IR.

## Key findings

  • In the abstract, mean VAI was 4.26 ± 3.23 in PCOS vs 2.61 ± 1.92 in controls (p = 0.003); mean DAI was 3.00 ± 1.86 in PCOS vs 1.86 ± 1.22 in controls (p = 0.003).
  • For diagnosing PCOS, VAI and DAI had limited performance: VAI AUC = 0.639 with cutoff 3.10 (56% sensitivity, 66% specificity), and DAI AUC = 0.635 with cutoff 0.22 (54% sensitivity, 67% specificity).
  • For predicting metabolic syndrome in PCOS, VAI performed well: cutoff 4.73, 62% sensitivity, 92% specificity, AUC = 0.870; DAI also performed well: cutoff 2.44, 74% sensitivity, 80% specificity, AUC = 0.862.
  • For predicting insulin resistance in PCOS, VAI had cutoff 2.56, 82% sensitivity, 56% specificity, AUC = 0.754; DAI had cutoff 1.59, 82% sensitivity, 55% specificity, AUC = 0.749.

## Methods

  • Retrospective cross-sectional study at a single outpatient clinic at Düzce University, conducted between October 2018 and June 2024, with ethical approval 2024/173.
  • Sample: 160 women aged 18–45 years; 92 PCOS cases diagnosed by 2023 Rotterdam criteria and 68 age-matched healthy controls; exclusions included major endocrine/systemic disease, medication use affecting metabolism/hormones, smoking, alcohol use, and incomplete records.
  • Data were extracted from medical records; fasting blood samples were used to measure glucose, insulin, lipids, and hormones; HOMA-IR, VAI, and DAI were calculated, and group comparisons plus ROC curve analysis were used to assess predictive performance.

## Limitations

  • The paper explicitly states that the cross-sectional design prevents causal inference.
  • The paper explicitly states it was a single-center study, which may limit generalizability.
  • The paper explicitly states that physical activity, dietary intake, and socioeconomic status were not assessed, which could have influenced results.
  • Evident from the text: the study is based on retrospective medical records, so it depends on available documentation and may be vulnerable to missing or unmeasured confounding.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/medicina61030424

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study flowchart showing inclusion and exclusion criteria.
Figure 1 Study flowchart showing inclusion and exclusion criteria.CC BY · PubMed Central
Figure 2 VAI and DAI ROC curves showing sensitivity and specificity values for individuals with and without PCOS.
Figure 2 VAI and DAI ROC curves showing sensitivity and specificity values for individuals with and without PCOS.CC BY · PubMed Central
Figure 3 VAI and DAI ROC curves showing sensitivity and specificity values for PCOS patients with and without MetS.
Figure 3 VAI and DAI ROC curves showing sensitivity and specificity values for PCOS patients with and without MetS.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 2 Not valid · 5 Not checked · 31 Own results and interpretations

22 more claims

Create a free account to see all 48 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 15

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. 2023, Visceral adiposity index (VAI) and dysfunctional adiposity index (DAI). Relationship with obesity parameters, Semergen, 49, 101965
  2. Akbaba, 2014, Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome, Noro Psikiyatr. Ars., 51, 129

Cited by

See all 11

Metadata

Authors
Keyif, B., & Yavuzcan, A.
Affiliations
  • Düzce Üniversitesi (TR)
  • Sağlık Bilimleri Üniversitesi (TR)
Corresponding author
Keyif, Betül
Venue
Medicina
Publisher
MDPI AG
Published
2025-02-28
Volume
61
Issue
3
Pages
424
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W4408056350
Cited by
11
References
37
Citations by year
2026: 6 · 2025: 5
FWCI
9.56
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
polycystic ovary syndrome, visceral adiposity index, insulin resistance, metabolic syndrome, visceral fat, adipose tissue dysfunction, type 2 diabetes risk, diagnostic biomarkers, women's health, Rotterdam criteria, metabolic syndrome prediction, obesity, dyslipidemia, hyperinsulinemia, hyperandrogenism, hypertriglyceridemia
MeSH terms
Adult, Cross-Sectional Studies, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, ROC Curve, Biomarkers, Metabolic Syndrome, Intra-Abdominal Fat, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study. https://app.cochat.ai/papers/10.3390/medicina61030424
The paper
Keyif, B., & Yavuzcan, A. (2025). Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study. Medicina. https://doi.org/10.3390/medicina61030424

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.